The balance between cell death and proliferation in the vessel wall influences neointimal formation, remodeling, and eventual luminal narrowing after arterial injury. In this study, the time course of apoptosis, proliferation, and expression of p27-a critical regulator of cell-cycle progression-is characterized in a mouse model of transluminal arterial injury associated with substantial neointimal formation. Methods: C57BL/6 mice underwent bilateral femoral artery injury by passage of an angioplasty guidewire. Expression of p27, Ki67 proliferative index, and apoptosis, as well as histomorphometry, were analyzed in cross sections of uninjured arteries and arteries harvested at different time intervals after injury. Results: In the uninjured arteries, no apoptotic cells were detected, and p27 and Ki67 were expressed in less than 5% of medial cells. After injury, apoptosis increased markedly in medial smooth muscle cells from 1 to 24 hours and decreased gradually thereafter. Ki67 proliferative index increased after 1 week, peaked at 2 weeks in both the media and neointima, and decreased thereafter. p27 expression was undetectable from 1 to 48 hours, and increased gradually from 1 to 4 weeks. Well-developed neointima was present at 2 and 4 weeks. Conclusions: In vivo injury to the mouse femoral artery evokes a rapid apoptotic response and downregulation of p27, followed by gradual increase in proliferation. During later phases of arterial repair, p27 expression increases while a shift of proliferation rates toward baseline occurs. Future experiments using this model in genetically modified mice may help identify specific cell-cycle regulatory molecules as therapeutic targets for control of pathologic arterial healing. (J Vasc Surg 2000;32:1022-9.)
Replication of smooth muscle cells (SMCs) is prominent during the arterial response to injury and is one of the hallmarks of pathologic vessel-wall healing. Proliferative lesions are seen not only in accelerated forms of arterial narrowing, such as anastomotic intimal hyperplasia and restenosis after angioplasty, but also in chronic atherosclerosis. [1] [2] [3] After arterial injury, cytokines and growth factors produced as part of the initial thrombotic and inflammatory response induce quiescent medial SMCs to enter the cell cycle and proliferate. 4 Progression through the cycle, however, is controlled by a series of cyclins, cyclin-dependent kinases (CDKs), and CDK inhibitors (CDKIs). 5 Cellcycle progression requires complexation of a cyclin and CDK. Activity of these cyclin-CDK complexes can be altered by CDKIs, which bind to and inactivate cyclin-CDK complexes, arresting the cell cycle. 6 Cell-Apoptosis, proliferation, and p27 expression during vessel wall healing: Time course study in a mouse model of transluminal femoral artery injury cycle arrest can redirect the cell toward apoptotic pathways. 7 Therefore, levels of these regulatory molecules influence quiescence, proliferation, and apoptosis in a cell population. In the injured arterial wall, the balance between proliferation and apoptosis rates has potential effects on both neointimal formation and remodeling.
Among inhibitors of cell-cycle progression, p27, a CDKI implicated in cell-cycle arrest induced by transforming growth factor-beta, cell-to-cell contact, and serum deprivation, is considered a major regulator of G1/S transition. 8 Like other members of the Cip/Kip family, including p21 and p57, p27 is ubiquitous; however, it binds preferentially to G1 cyclin-CDK complexes. 5, 9 A role in modulating apoptosis also has been proposed on the basis of studies using p27-deficient fibroblasts and mesangial cells. 10 The inhibitory effect of p27 on proliferation has been shown in vascular SMC. 11 Although the importance of studying molecular targets with potential to alter the proliferative response has become increasingly clear, lack of appropriate in vivo models has limited such studies. 12 Therefore, expressions of p27 and Ki67 (a marker of proliferation), as well as apoptosis, were analyzed in a mouse model of transluminal arterial injury. 13, 14 This model, described recently, simulates many aspects of human restenosis, and could be beneficial as a means of investigating molecular events involved in the restenotic process in genetically modified mice. This study, using wild-type mice, demonstrates the sequential expression of cell-cycle regulation markers during the vessel wall response to injury, and validates mouse femoral arterial injury as an experimental tool to examine such events.
METHODS

Animals.
A total of 20 wild-type mice of the inbred strain, C57BL/6 (Taconic Farms, Germantown, NY) were used. (This strain is common as background in transgenic and knockout mice.) Mice were housed at the Center for Laboratory Animal Sciences, The Mount Sinai Medical Center, NY, and received a standard rodent chow (PMI Nutrition International, St Louis, Mo) and tap water ad libitum. Animal care and experimental procedures conformed with the "Guide for the Care and Use of Laboratory Animals" (Department of Health, Education, and Welfare, Publication No NIH 78- 23, 1996) , and were approved by the Institutional Animal Care and Use Committee.
Experimental design. Histologic sections of mouse arteries obtained at various time points after injury were examined to determine the time course of cell-cycle markers and apoptotic cell death in the arterial wall. Specimens noted to be inadequate for histologic analysis (n = 2) or containing arteries with occlusive thrombus (n = 4) were excluded. Arteries harvested at 1 (n = 2), 6 (n = 2), 12 (n = 2), 24 (n = 2), and 48 (n = 2) hours, and 7 (n = 9), 14 (n = 6), and 28 (n = 5) days after injury were analyzed. Expressions of p27 and Ki67, as well as apoptosis, were determined, correlated with histology, and compared with normal, uninjured arteries (n = 4) used as controls, representing baseline values.
Arterial injury protocol. Male mice, 3 to 4 months old (weight, approximately 25 g), were used. Bilateral femoral arterial injury was performed as described. 14 Mice were anesthetized with pentobarbital (40 mg/kg body weight, intraperitoneal; Nembutal, Abbott Laboratories, North Chicago, Ill), and placed in the supine position with lower extremities extended. The surgical procedures were performed under magnification, using a surgical microscope (Carl Zeiss, Thornwood, NY). A groin incision was made, and the segment of femoral artery between epigastric and saphenous arteries was dissected free from the vein. (For anatomy of mouse femoral vessels, see Zhang et al. 15 ) After the femoral vessels were clamped at the level of the inguinal ligament, an arteriotomy was made on the femoral artery, approximately 1 mm distal to the epigastric branch. A 0.010-in (0.25-mm) diameter angioplasty guidewire (Advanced Cardiovascular Systems, Temecula, Calif) was introduced into the arterial lumen, the clamp removed, and the wire advanced and pulled back three times, each time reaching the aortic bifurcation. The wire was then removed, and arteriotomy site ligated with 8-0 nylon sutures (U.S. Surgical, Norwalk, Conn). The same protocol was carried out on the contralateral side.
Histology, immunohistochemistry, and apoptosis assessment. For harvesting of specimens, after deep anesthesia with pentobarbital (50 mg/kg body weight), mice were perfusion fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS, pH = 7.4) solution at 100 mm Hg for 5 minutes. The perfusate was infused through a cannula (18 ga; Angiocath, Becton Dickinson, Sandy, Utah) inserted in the left ventricle, and drained through an incision in the right atrium. The hindlimbs and pelvis were excised en bloc, fixed in 4% paraformaldehyde in PBS solution overnight, and decalcified in 10% formic acid for 24 hours. The thighs, containing the femoral vessels, were cut transversely; the common femoral artery (approximately 4-mm length from inguinal ligament to epigastric branch) was divided into 2-mm segments. Specimens underwent standard dehydration and paraffin embedding. Sequential November 2000 cross-sections (thickness: 5 µm) cut from the midportion of the femoral artery were stained with combined Masson-elastic (CME) 16 and hematoxylineosin, or processed for immunohistochemistry.
Representative sections were treated with antibodies to Ki67 (1:1000; rabbit polyclonal, NovoCastra, Newcastle, UK), p27 Kip1 (1:30,000; affinity purified rabbit polyclonal antibody against murine p27 fusion protein; provided by Dr A. Koff, Memorial Sloan-Kettering Cancer Center, New York, NY), factor VIIIrelated antigen (Rabbit Anti-Human Von Willebrand Factor [vWF], Dako, Denmark; 0.57 µg/mL), and αactin (alkaline-phosphatase-conjugated monoclonal anti-α-smooth muscle actin; 1:100; Sigma, St Louis, Mo). Sections were immersed in boiling 0.01 mol/L citric acid (pH 6.0) for 15 minutes for antigen retrieval, and incubated with primary antibodies overnight at 4°C. Biotinylated goat antirabbit IgG antibodies were applied for 1 hour (1:500; Vector Laboratories, Burlingame, Calif), followed by avidinbiotin peroxidase complexes for 30 minutes (1:25; Vector Laboratories). Diaminobenzidine was used as final chromogen, and hematoxylin for nuclear counterstaining. Negative controls were prepared by substituting the primary for an irrelevant antibody. Positive control for Ki67 was mouse lymph node; for p27, mouse thymus; for vWF, normal-artery endothelium; and for α-actin, normal-artery media.
For the assessment of apoptosis, sections were stained by a terminal deoxytransferase-mediated dUTPbiotin nick end-labeling (TUNEL) assay, modified from that described by Gavieli et al. 17 This noncommercial assay is based on specific binding of terminal deoxinucleotinyl transferase (TdT) to 3´-OH ends of DNA to ensure synthesis of a polydeoxynucleotide. After exposure of nuclear DNA of histologic sections by treatment with 20 µg/mL proteinase K, TdT buffer was applied for 15 minutes. A reaction mixture of 0.1 mmol/L DDT, 0.5 µL TdT, and 0.07 mmol/L biotin-11 dUTP was applied for 1 hour to promote insertion of biotinylated deoxyuridine at sites of DNA breaks. The signal was amplified by avidin-biotin peroxidase complexes for 30 minutes and visualized by diaminobenzidine deposition to allow histochemical identification of reactive nuclei by light microscopy-brown staining, in contrast with nonimmunoreactive, hematoxylin counterstained, blue nuclei. Positive controls for TUNEL were moderately (2 rads) and severely (10 rads) irradiated mouse thymuses harvested 8 hours after irradiation. Analysis of histologic cross sections. Each cross-section was analyzed by two separate investigators in a blind coded fashion. For computerized morphometry, 18 images were captured from a video camera attached to a light microscope, and digitized. The two CME-stained cross-sections from each artery were measured (NIH Image 1.60 software) and results averaged. Luminal area (LA), the area bounded by internal elastic lamina (IEL) that corresponds to the LA in the absence of intimal lesions, and the area encircled by external elastic lamina (EEL) that corresponds to overall vessel size, were obtained. Derived calculations included media area (EEL area minus IEL area), intimal area (IA; IEL area minus LA), and percentage of luminal narrowing ([IA/IA+LA] × 100).
Immunohistochemistry for p27 and Ki67 was assessed at ×400 magnification. Given the small size of mouse arteries, all cells in the media, neointima, and endothelium were counted. Cells with positive nuclear immunoreactivity (brown staining) were scored, and the percentage of positive cells relative to total number of nuclei was calculated.
Endothelial coverage (low-profile cells with central nuclei coating the luminal surface) was assessed on sections stained for vWF and CME. The length of the monolayer of endothelial cells also was measured, and divided by the length of luminal surface.
Statistics. Numeric data are expressed as mean ± SEM. Analysis of variance (ANOVA) was used to determine differences among results of the various time points. Student t test was used for comparisons between two different time points. P values less than .05 were considered significant.
RESULTS
Endothelial denudation and neointimal formation.
Histomorphometric data on injured arteries are summarized in the Table. Early after injury, arteries displayed complete endothelial denudation. Progressive endothelial coverage (percent of luminal surface on cross section) was observed, and complete reendothelialization was reached by 28 days. Intimal hyperplasia, defined as any proliferative lesion within the internal elastic lamina circumference, was absent at early time points, and increased gradually from 7 to 28 days. Mean intima-to-media (I/M) ratio of 1.1 ± 0.1, and luminal narrowing of 23% ± 3% were obtained by day 28. SMC was the major cell type within the neointima, as confirmed by α-actin staining.
Time course of apoptosis in the vessel wall. Apoptosis was absent in uninjured vessels. After injury, apoptosis was noted as early as at 1 hour. Highest apoptotic rates were noted from 6 to 24 hours (P < .05 vs controls) in the media, and remained elevated from 1 to 7 days. At 14 days, whereas medial apoptotic index had decreased, high levels (32%) of apoptosis were observed in the developing neointima. In the endothelium, apoptosis rates were low-to-undetectable throughout the 4week period. The distribution of apoptosis in the femoral arterial wall at representative time intervals after injury is illustrated in Figs 1, A, and 2 cells. No significant Ki67 expression was found in the vessel wall by 24 hours after injury. By 7 days, proliferative activity was noted in the media, neointima, and endothelium (P = NS), reaching maximal levels at 14 days (P < .05 vs controls). At 28 days, Ki67 expression was decreased in all layers to levels comparable to baseline (Figs 1, B, and 2, B) .
Time course expression of p27. p27 was present in less than 5% of medial SMC in uninjured arteries. After injury, p27 was absent between 1 and 48 hours. A gradual increase in p27 expression was observed in all layers of the vessel wall from 7 to 28 days following injury. At 7 days, p27 was found in medial SMCs and regenerated endothelium (P = NS vs controls). At 14 days, expression levels were higher throughout the vessel wall (P < .05 vs controls), including a small percentage of cells in the developing neointima. By 28 days, p27 reached highest levels of expression in the media and neointima (P < .05 vs controls) (Figs 1, C, and 2, C) .
Temporal sequence of apoptosis, proliferation, and p27 expression. An acute and transient increase in apoptosis occurred after injury, followed by high proliferation rates, which later also declined. Increased levels of p27 expression found toward late phases suggest upregulation of p27 modulates the inhibitory response to proliferation. After the peak of apoptosis (6 hours after injury), a gradual decrease in apoptotic rates was paralleled by progressive increase in Ki67 proliferative index from 1 day to 1 week. At 2 weeks, cell proliferation peaked (26% ± 5%), associated with a second peak of apoptosis (28% ± 4%), primarily in the neointima. Equilibrium between apoptosis (15% ± 6%) and proliferation (11% ± 3%) was maintained at 4 weeks. p27 expression peaked at 2 weeks (18 ± 3%), and persisted high by 4 weeks (16% ± 5%), concomitant with the decreasing proliferative index. Temporal expression of these markers in the femoral arterial wall is illustrated in Fig 3. 
DISCUSSION
Interest in the response to arterial injury in mice has grown as a result of the increasing availability of genetically modified mice, which represent useful systems to study specific molecules in vivo. 19, 20 This study was designed to determine the temporal expression of cell-cycle markers in the mouse arterial wall during neointimal formation. At early time points after femoral artery denudation, a prominent apoptotic response occurred, whereas proliferation and p27 expression were absent. After the first week, a proliferative response ensued (increasing Ki67 levels), accompanied by increasing expression of p27. High p27 levels were associated with decreased proliferation rates. In combination, these findings suggest p27 upregulation as a mechanism of controlling proliferation during vessel-wall healing.
The technique of injury to the femoral artery used in this study results in substantial amounts of intimal hyperplasia and is highly reproducible. 13, 14 In this model, the endothelium is denuded by repeated passage of an angioplasty guidewire. The time course of neointimal formation is similar to that reported after balloon injury in rabbits, 21 pigs, 22 and baboons. 23 I/M ratios also are comparable with those obtained in larger animals. 2 As in other models, and in some cases of human restenosis, favorable remodeling also has been noted in this model. 14 Although other techniques of injury have been described in mice, most of them use external approaches (eg, periarterial cuff, 24 electric current, 25 or arterial ligature 26 ) and, thus, differ from usual clinical scenarios in which injury is transluminal, as in balloon angioplasty of coronary or peripheral arteries. One exception, wire denudation of the mouse carotid, 27 is considered difficult technically, and is prone to variability. 28 The enzymatic activity of cyclin-CDK complexes is modulated by binding of CDKIs. 8 Cyclin-CDK complexation allows hyperphosphorylation of retinoblastoma protein and release of E2F transcription factor, essential for progression through S phase. The transition between G1 (protein synthesis) and S (DNA synthesis) phases is critical because cell-cycle progression becomes irreversible after the G1 restriction point; the cell either replicates or undergoes apoptotic death. p27 is one of the principle negative regulators of cell-cycle progression, inhibiting a variety of cyclin-CDK complexes throughout the cell cycle. 5 Intracellular levels of free p27 determine the threshold for cell entry into S phase. 29 Altered expression of p27 occurs in many proliferative disorders, including cancer, 30 where p27 overexpression is thought of as a defense mechanism against excessive proliferation. 31, 32 Genetically modified mice lacking p27 function have accelerated growth, multiple organ hyperplasia, and a high incidence of tumors. 33 Cell death can occur by two distinct processes, either necrosis or apoptosis. Necrosis defines passive cell death with loss of membrane integrity and marked inflammatory response. Apoptosis is an active process involving preprogramed intracellular signaling, which leads to cell phagocytosis without inflammatory reaction. Apoptosis is a homeostatic process that helps maintain cell mass and tissue structure; cell proliferation is compensated by loss due to apoptosis under normal conditions. 7 In chronic atherosclerosis, apoptosis rates are higher in SMCs within fibroproliferative lesions than in normal medial layers, which may contribute to plaque instability. 34 A rapid and prominent rise in medial SMC apoptosis was found in the current study; apoptosis was detected as early as 6 hours after injury. As the healing response continued, proliferation ensued and apoptotic rates decreased gradually. This early and transient apoptotic response also has been described after rat carotid balloon denudation, 35 and pig coronary angioplasty. 36 In the pig coronary artery, early apoptosis is seen primarily in the media bordering the lumen, consistent with a more severe damage to inner medial layers associated with transluminal injury.
Ki67 proliferative index increased after the peak of apoptosis and decreased in later phases, concomitant with increased expression of p27. Distribution of proliferating SMC, as assessed by Ki67 immunostaining, indicates the progressive increase in proliferation peaks between 7 to 14 days after injury. Using tritiated thymidine, Lindner et al 27 reported highest replication rates by the second week after carotid injury in mice. This earlier peak may represent a different response of carotids compared with femoral arteries. 37 Between 2 and 4 weeks, an equilibrium between proliferation and apoptosis rates was observed in the current study. This finding is consistent with previous studies suggesting the number of cells does not increase significantly in later stages of vascular repair. 2 Decreased proliferation was associated with raising expression of p27, consistent with its expected negative regulatory effect on cell-cycle progression. Levels above baseline were reached and appeared to stabilize by 28 days, as if the homeostatic balance in the vessel wall had been reestablished. Similar patterns of expression have been described in experimental arterial injury, such as in the pig iliofemoral artery 11, 38 and rat carotid, 6 supporting the concept that p27 functions as an inhibitor of proliferation in late phases of arterial repair. 32 In summary, this study shows that transluminal arterial injury induces a rapid apoptotic response, Histology and morphometry of mouse femoral arteries after transluminal endothelial denudation followed by progressive increase in SMC proliferation. As the healing process advances, including development of a neointima, p27 is upregulated, which suggests a role in controlling the ensuing proliferation and reestablishing quiescent phenotype. In the mouse, the temporal sequence of expression of these markers resembles composite curves of various studies using other animal models, 39 which indicates levels of expression of cell-cycle regulatory molecules after arterial injury follow a predictable course across species. Therefore, these experiments validate femoral arterial injury in the mouse as a model for studying intimal hyperplasia and, in particular, interactions between promitogenic and antimitogenic stimuli within the vessel wall during the response to injury. Application of this injury model in genetically modified mice should help further define cellcycle regulatory pathways participating in arterial stenosis and restenosis.
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